Targeting caspase-8/c-FLIPL heterodimer with small molecule FLIPinB in combination with death ligands, gemcitabine and Mcl-1 inhibitor efficiently eliminates pancreatic cancer cells via promoting complex II assembly. Here, CASP8 is linked to familial pancreatic carcinoma.